Retatrutide Outperforms Ozempic in Direct Comparative Trial | Retatrutide News

Eli Lilly's retatrutide outperformed Ozempic in a head-to-head trial, according to Clinical Trials Arena. This suggests retatrutide may offer greater be...
Clinical Trials · October 29, 2026